Angiotensin II Receptor Blockade Reduces New-Onset Atrial Fibrillation and Subsequent Stroke Compared to Atenolol. The Losartan Intervention for End Point Reduction in Hypertension (LIFE) Study

✍ Scribed by K. Wachtell; M. Lehto; E. Gerdts

• Book ID: 113415122
• Publisher: Elsevier Science
• Year: 2005
• Tongue: English
• Weight: 34 KB
• Volume: 14
• Category: Article
• ISSN: 1062-1458
• DOI: 10.1016/j.accreview.2005.05.064